Mitral valve prolapse: Definition and implications in athletes  by Jeresaty, Robert M.
JACC Vol. 7. No I 
January 1986:231-6 
231 
Mitral Valve Prolapse: Definition and Implications in Athletes 
ROBERT M. JERESATY, MD, FACC 
Hartford and Farmington. Connecticut 
Mitral valve prolapse is probably the most common car•
diac valve disorder, affecting approximately 5 % of the 
population. Although it is genetically determined, its 
clinical manifestations do not usually become evident 
before adulthood. In the setting of a cardiology referral 
center, a mitral valve prolapse syndrome, consisting of 
nonspecific symptoms, repolarization changes on the 
electrocardiogram and arrhythmias, has been identified. 
However, doubt has recently been expressed about the 
existence of such a syndrome. The prognosis of mitral 
valve prolapse is generally favorable but infrequent com•
plications do occur and include transient ischemic at•
tacks, progression of mitral regurgitation with or with•
out ruptured chordae tendineae, infective endocarditis 
Mitral valve prolapse was first identified (1,2) as a clinical•
pathologic entity in the mid 1960s when the midsystolic 
click and the late systolic murmur were correlated with the 
demonstration of angiographic protrusion of the mitral leaf•
lets into the left atrium and late systolic regurgitation. This 
syndrome continues to generate great interest and remains 
the subject of an unprecedented information explosion. De•
spite the outpouring of information, much of it remains 
incomplete, contradictory and controversial (1-3). More•
over, careful studies of mitral valve prolapse in the athlete 
are notoriously lacking. In this report, the implications of 
mitral valve prolapse, as it relates to recommendations on 
participation in competitive activities, will be formulated in 
the context of its cause, pathology and clinical findings and 
complications. 
Scope of the Problem 
Mitral valve prolapse is probably the most common car•
diac valve disorder. Although the abnormality may be ge•
netically determined, its clinical manifestations do not usu-
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and sudden death. The symptoms and the complications 
are not usually related to physical activity. 
A permissive attitude toward participation of patients 
with mitral valve prolapse in competitive athletics is 
probably warranted; however, it would appear reason•
able to disqualify athletes with mitral valve prolapse in 
the following circumstances: 1) history of syncope; 2) 
disabling chest pain; 3) complex ventricular arrhyth•
mias, particularly if induced or worsened by exercise; 
4) significant mitral regurgitation; 5) prolonged QT in•
terval; 6) Marfan's syndrome; and 7) family history of 
sudden death. 
(J Am Coil CardioI1986;7:231-6) 
ally become evident before adulthood (1). However, the 
symptoms associated with mitral valve prolapse, particularly 
chest pain, fatigue and palpitation, and the serious yet un•
common complications of this syndrome (especially sudden 
death and ruptured chordae tendineae) have a definite bear•
ing on those who participate in athletics and on their possible 
disqualification from strenuous and competitive activities. 
Etiology and Basic Structural Definition 
The basic structural abnormality of mitral valve prolapse 
is the systolic protrusion of the mitral valve leaflets or their 
scallops beyond the mitral anulus into the left atrium as 
demonstrated by angiography, echocardiography and patho•
logic examination. Although the cause of this syndrome 
remains controversial, two main theories have been pro•
posed: the valvular theory stresses mitral valve abnormality 
as the cause and the myocardial theory ascribes this syn•
drome to primary myocardial involvement (1). 
According to the valvular theory, myxomatous transfor•
mation is the underlying mechanism responsible for mitral 
valve prolapse and the associated click. Myxomatous trans•
formation is characterized by disruption and loss of normal 
valvular architecture with thickening of the spongiosa, which 
is rich in acid mucopolysaccarides. The thickened spongiosa 
encroaches on the fibrosa, interrupting it focally and causing 
a basic weakness of this supporting structure, leading to 
redundancy and prolapse (4). The mitral valve anulus is 
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usually enlarged. The valvular theory has been confirmed 
pathologically and surgically by the finding of myxomatous 
and redundant mitral cusps in more than 30 patients known 
to have had a mid systolic click (1,5,6). 
The myocardial theory is based primarily on angiographic 
and hemodynamic findings (1). In view of the high prev•
alence of mitral valve prolapse and the generally benign 
outlook of this syndrome (3), an important myocardial com•
ponent would be highly unlikely. There is little evidence to 
warrant the diagnosis of myocardial disease in the young 
athlete with mitral valve prolapse. Autonomic dysfunction 
with a predominant high adrenergic tone has been reported 
in mitral valve prolapse (7,8). 
Prevalence, Sex and Age Distribution 
The prevalence of mitral valve prolapse increases with 
age (9). To quote Leatham and Brigden (10), "the incidence 
of mitral valve prolapse increases greatly with age, sug•
gesting a 'wear and tear' effect superimposed on a minor 
congenital abnormality of the cusps and chordal tissue." 
This syndrome has been reported in children and adolescents 
(11-19); however, with the exception of one survey (13), 
its prevalence has been lower than in adults. In the aus•
cultatory survey by McLaren et aL (11), of 12,050 children 
in Soweto, South Africa, 1.5% were found to have a non•
ejection click. Chandraratna et aL (13) studied 100 clinically 
stable newborn infant girls and observed a 7% (3 infants 
with auscultatory and echocardiographic evidence and 4 
with isolated echocardiographic abnormalities) prevalence 
of mitral valve prolapse. 
A female preponderance has been reported in this syn•
drome, women constituting approximately two-thirds of pa•
tients with idiopathic mitral valve prolapse (1). The true 
prevalence of this disorder in the general population has not 
yet been established and the results of surveys are variable. 
A 6% prevalence is probably the most accurate for a young 
female population and, in view of the known female pre•
ponderance, a 5% prevalence for the general population can 
be extrapolated (1). An autosomal form of inheritance with 
incomplete penetrance and reduced expressivity in the male 
and the young has been noted in this syndrome (1). 
Symptomatology 
In the setting of a cardiology referral center, chest pain, 
dyspnea, fatigue, dizziness, palpitation and neuropsychia•
tric disorders are commonly encountered in patients with 
mitral valve prolapse (I). In epidemiologic surveys, how•
ever, most of the patients are asymptomatic and, recently, 
doubt has been expressed about the existence of a distinct 
mitral valve prolapse syndrome including symptoms, 
electrocardiographic abnormalities and arrhythmias (21). 
Chest pain, the most common and potentially disabling 
symptom, is usually sharp, left precordial and either fleeting 
or of several hours' duration (2). It occurs in 6lo/c of our 
patients (20) and, in about 89% of them, it is unrelated to 
physical activity. Children and adolescents with mitral valve 
prolapse may present with the same symptoms as adults 
(14,17,19) but at a lesser frequency. 
Auscultatory Findings 
There are seven major auscultatory manifestations of 
mitral valve prolapse: isolated mid-systolic click, mid-sys•
tolic click followed by a late systolic murmur, early systolic 
click, isolated late systolic murmur, pansystolic murmur, 
precordial honk and "silent" form. Physiologic and 
pharmacologic maneuvers can alter the timing of the click 
and murmur (1,2). 
The mid- to late systolic click is generally accepted as 
the diagnostic hallmark of this syndrome and its mere pres•
ence on auscultation, preferably with phonocardiographic 
confirmation, would warrant, except in a few instances, the 
diagnosis of mitral valve prolapse (1). In the presence of a 
click, echocardiography, which is positive for mitral valve 
prolapse in 80% of patients with a click, is not required for 
the diagnosis. However, in the absence of a click ("silent" 
form) and in patients with an early click, isolated late sys•
tolic murmur, honk or pansystolic murmur, the diagnosis 
of mitral valve prolapse can only be established by means 
of echocardiography or angiography. The "silent" form is 
the most uncommon in children: of 119 patients with mitral 
valve prolapse only 1 "silent case" was reported by Bisset 
et aL (19). In my experience and that of others (1,9), mul•
tiple clicks and precordial honks in young patients have 
sometimes been mistaken for a pericardial friction rub by 
referring physicians. 
The general physical appearance in mitral valve prolapse 
may be entirely normaL However, certain features, that is, 
asthenic body habitus, high arched palate and thoracic skel•
etal abnormalities (straight back, pectus excavatum and sco•
liosis), are frequently noted and heighten suspicion of this 
syndrome (2,22,23). 
Electrocardiographic Findings 
T wave changes. Electrocardiographic abnormalities, 
noted primarily in the inferior limb leads, consist of initially 
inverted or totally inverted T waves with or without ST 
segment depression (20). These abnormalities may also be 
evident in the left precordial leads, and, in a few patients, 
they may be widespread. Therefore, if abnormal T waves 
are noted on a routine electrocardiogram in a young athlete, 
mitral valve prolapse should be kept in mind in the differ•
ential diagnosis. However, because biphasic or negative T 
waves are not uncommon in the athlete (24), they are not 
necessarily due to mitral valve prolapse when this syndrome 
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is present. The finding of the high prevalence of mitral valve 
prolapse (4 patients) and hypertrophic cardiomyopathy (3 
patients) in 12 top ranking athletes with pseudo-ischemic T 
waves awaits further confirmation (25). Prolongation of the 
QT interval has been reported, but its true prevalence and 
significance have not been defined. Thallium 201 scintig•
raphy, when results are normal, is helpful in eliminating 
associated coronary artery disease as a cause of repolari•
zation abnormalities in mitral valve prolapse, 
Arrhythmias. Ventricular and atrial arrhythmias are 
probably the most common manifestation of mitral valve 
prolapse. Using ambulatory electrocardiographic monitor•
ing in 31 patients with mitral valve prolapse, DeMaria et 
al. (26) observed premature ventricular complexes in 58%, 
supraventricular arrhythmias in 35% and brady arrhythmias 
in 29%, Winkle et al. (27) reported a 75% incidence of 
ventricular arrhythmias in mitral valve prolapse. In both 
investigations ambulatory monitoring was more sensitive 
than stress testing in the detection of arrhythmias. A lower 
prevalence of arrhythmias has been reported in the pediatric 
age group. In 26 un selected pediatric patients with mitral 
valve prolapse (age 7 to 18 years) studied with graded ex•
ercise treadmill testing and 24 hour ambulatory electrocar•
diographic monitoring, Kavey et al. (28) detected poten•
tially serious ventricular arrhythmias in 6 (23%), of whom 
5 manifested the arrhythmia on exercise testing. Neither 
standard electrocardiographic abnormalities nor clinical 
symptoms correlated with the arrhythmia. A similar prev•
alence of ventricular arrhythmias (21 %) was reported by 
Bisset et al. (19) in 43 children. 
Bradyarrhythmias and conduction defects. These have 
also been reported in this syndrome but have been rare. It 
is of interest that mitral valve prolapse was noted in 3 of 
10 top ranking athletes with Wenckebach second degree 
atrioventricular (A V) block (29). An immediate normaliza•
tion of A V conduction was obtained with reflex sympathetic 
stimulation, sympathomimetic or vagolytic drugs and phys•
iologic exercise. No deterioration of A V conduction was 
noted and the prognosis of this vagally induced benign fea•
ture of the athlete's heart was judged to be favorable. 
Ventricular fibrillation is the probable mechanism of sud•
den death, a rare occurrence in mitral valve prolapse (l). 
Echocardiographic and 
Angiographic Findings 
Echocardiography. This procedure is, along with aus•
cultation and angiography, an important diagnostic marker 
in mitral valve prolapse. Pansystolic sagging (hammocking) 
or late systolic dipping of the mitral valve echo are the 
characteristic findings on M-mode echocardiography, Late 
systolic dipping is less sensitive but much more specific 
than hammocking in the diagnosis of mitral valve prolapse. 
Hammocking is affected by the position of the transducer, 
being induced by a high position, and masked by a low 
position. To be helpful in the diagnosis of mitral valve 
prolapse, hammocking should be pronounced (2:3 mm). 
Two-dimensional echocardiography is probably indicated in 
all patients who exhibit isolated hammocking and may be•
come the standard for the diagnosis of mitral valve prolapse, 
particularly in controversial cases (30). It enables the rec•
ognition of the superior as well as of the strictly posterior 
prolapse. Moreover, it can identify structural abnormalities 
of the mitral valve consisting of thickening and redundancy. 
Angiography. Left ventricular angiography is helpful in 
the diagnosis but is not usually required. The angiographic 
findings may be nonspecific and should, therefore, be cor•
related with the clinical and echocardiographic data before 
a diagnosis of idiopathic mitral valve prolapse can be made. 
Prognosis and Complications 
The prognosis in mitral valve prolapse is generally fa•
vorable (l ,3), particularly in children (16,19). Patients with 
an isolated click and those with the "silent" form constitute 
a low risk group (I). Bisset et al. (19) studied 119 children 
and adolescents for a mean follow-up period of 6 to 9 years. 
No progression of mitral regurgitation was observed and 
there were no sudden deaths, One patient developed infec•
tive endocarditis and one had a cerebrovascular accident. 
Complications. Despite its generally benign outlook, 
this syndrome may infrequently become complicated by 
transient ischemic attacks that are thought to be due to 
platelet and fibrin embolization originating from the mitral 
valve (31) by ruptured chordae tendineae, progression of 
mitral regurgitation, infective endocarditis or sudden death. 
The risk of infective endocarditis warrants the use of anti•
biotic prophylaxis in patients with mitral valve prolapse 
when a regurgitant murmur is present. In our experience 
(32) with 25 patients with surgically proved ruptured chor•
dae tendineae, idiopathic mitral valve prolapse was the un•
derlying anatomic lesion in 23 (92%). Current evidence 
indicates that myxomatous transformation of the mitral valve 
is probably the most common cause of "spontaneous" chor•
dal rupture. None of our patients were in the young age 
group and the rupture occurred during physical stress (chop•
ping wood) in only one patient. 
Sudden death. This is the most feared complication of 
mitral valve prolapse, Fortunately, this catastrophic event 
is a rare complication of this syndrome and, to my knowl•
edge, only 60 cases (1,5,6,9,33-38) have been reported, It 
is possible that there is a larger number of patients with 
sudden death that go unreported. The age of these patients 
ranged from 9 to 79 years; only four were 20 years or 
younger (age 9,14,17,19 and 20, respectively). Two chil•
dren not included in this sudden death series developed 
ventricular arrhythmia and cardiac arrest and were success•
fully resuscitated (18), Among the four young patients who 
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died suddenly, I have included a 17 year old football player 
(35) who had at necropsy alterations of the mitral valve 
consistent with mitral valve prolapse and a family history 
of that disease, However, his heart weighted 530 g and the 
"abnormality" of the mitral valve was relatively mild; 
therefore, it was probably not responsible for significant 
mitral regurgitation and the degree of left ventricular hy•
pertrophy that was present. In addition, this athlete had 
severe narrowing of the artery to the A V node, which is 
not a known complication of mitral valve prolapse, 
Death occurred during physical stress in only three pa•
tients; one, aged 39, died while mowing his lawn (39), the 
second, aged 31, died after a game of tennis (40) and the 
third, a 17 year old boy, died during football scrimmage 
(36). Only one of these three patients was a trained com•
petitive athlete (36). Sudden death has been reported in only 
one patient with "silent" mitral valve prolapse (37) and in 
only a few patients with an isolated click (1,6,37). It would 
seem that the patient with mitral valve prolapse and a late 
or pansystolic murmur is at a higher risk of dying suddenly 
and of developing ruptured chordae tendineae and bacterial 
endocarditis than is the patient with "silent" mitral valve 
prolapse or isolated click (1,41), 
The rare occurrence of sudden death in mitral valve pro•
lapse should not be mentioned to the patient or his or her 
family for fear of arousing undue anxiety or possibly in•
ducing psychoneurosis. 
Clinical Presentations in the Young and 
Diagnostic Work-Up of the Athlete With 
Mitral Valve Prolapse 
Clinical features. The clinical presentations of mitral 
valve prolapse in the young are variable, This syndrome 
can present as an auscultatory complex of a click or murmur, 
or both, or a symptomatic complex characterized by chest 
pain, fatigue, dyspnea. syncope and palpitation. It may also 
manifest itself by the appearance of premature beats detected 
on auscultation and on a routine electrocardiogram by the 
occurrence of supraventricular tachycardia or the detection 
of repolarization changes, or both. In young patients with 
these symptoms, particularly in those with atypical chest 
pain and ventricular or supraventricular arrhythmias, a thor•
ough auscultation in various positions (supine, left decu•
bitus, sitting and standing, before and after squatting) should 
be carried out to detect a click or murmur, or both. The 
diagnosis of mitral valve prolapse is primarily clinical and 
is based on the discovery of a nonejection click. In the 
absence of a click, an echocardiogram is needed to establish 
a diagnosis. 
Diagnostic work-up. An electrocardiogram should be 
part of the diagnostic studies performed to determine the 
presence of repolarization changes that may be associated 
with complex arrhythmias (42). Cardiac catheterization and 
left ventriculography are only indicated when other forms 
of congenital heart disease are suspected or severe mitral 
insufficiency is noted. 
Holter monitoring and stress testing. In the presence 
of asymptomatic mitral valve prolapse, ambulatory electro•
cardiographic monitoring or stress testing is not indicated 
as part of the work-up. However, in the presence of symp•
toms, particularly palpitation, dizziness, near-syncope or 
syncope, and in the presence of premature beats on aus•
cultation and electrocardiography, both Holter monitoring 
and stress testing are advisable for evaluation of the mech•
anism of the symptoms and to help the physician formulate 
a recommendation. It is important to recognize that patients 
with mitral valve prolapse may have symptoms in the ab•
sence of arrhythmias or conduction defects and that symp•
toms should be correlated with specific electrocardiographic 
changes (43). Although ambulatory monitoring may detect 
a higher prevalence of arrythmias (27) than does exercise 
testing, the clinical value of these tests may be additive. 
Moreover, observation of the athlete during exercise is in•
valuable for adequate clinical assessment and sound 
recommendations, 
Marfan's syndrome. In evaluating the young athlete 
with mitral valve prolapse, Marfan's syndrome should be 
ruled out because the risk of aortic rupture and dissection 
in this syndrome represents a contraindication to competitive 
activities and contact sports, particularly if dilation of the 
ascending aorta is present. Mitral valve prolapse is common 
in Marfan's syndrome (44); however, oculoskeletal stigmata 
of Marfan's syndrome have been infrequent in large series 
of cases of mitral valve prolapse, being present in only 4 
of our 350 patients (1). Thus, despite the high prevalence 
of mitral valve prolapse in Marfan's syndrome, an uncom•
mon disease, there is a rare occurrence of Marfan's syn•
drome in mitral valve prolapse, a common disorder. 
Criteria for Disqualification of Athletes With 
Mitral Valve Prolapse From Competition 
The dearth of documented serious complications in mitral 
valve prolapse, particularly in the young, the lack of cor•
relation between symptoms (chest pain) and major compli•
cations (ruptured chordae tendineae, sudden death) and the 
lack of correlation between these complications and physical 
effort would warrant a permissive attitude toward partici•
pation of patients with mitral valve prolapse in athletics. 
However, hard data on which to base a judgment are not 
yet available. The prognosis of both ventricular and supra•
ventricular arrhythmias detected with either exercise testing 
or ambulatory electrocardiography in patients with mitral 
valve prolapse is unknown (45). However, the demonstra•
tion of no, infrequent or benign premature ventricular com•
plexes on Holter monitoring and the lack of occurrence of 
complex ventricular arrhythmias on stress testing would pro-
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vide the physician with objective evidence favoring a per•
missive attitude toward athletic participation. It is more 
difficult to arrive at a definitive recommendation regarding 
participation in athletic activities when apparently important 
arrhythmias are documented. 
Reasons for disqualification from competition in 
strenuous activities. Recognizing the lack of definitive data 
at the present time, it would appear reasonable to consider 
disqualifying athletes with mitral valve prolapse from com•
petition or other strenuous activities if they fall into any of 
the following categories: 
1) Patients with a history of syncope. Since syncope may 
be due to an arrhythmia, a vasovagal reaction or or•
thostatic hypotension, it is advisable to evaluate with 
Holter monitoring and exercise testing all patients with 
mitral valve prolapse with a history of syncope. 
2) Patients with disabling chest pain, particularly if the pain 
is made worse by exercise. 
3) Patients with complex ventricular arrhythmias (frequent, 
multifocal, occurring as pairs or runs or Ron T beats). 
These arrhythmias are especially of concern if they are 
induced or made worse by exercise. 
4) Patients with significant mitral regurgitation associated 
with moderate to marked cardiomegaly (46). However, 
in patients with a late systolic murmur or a pansystolic 
murmur with no cardiomegaly and no exertional symp•
toms, all recreational activities can probably be allowed 
(46). 
5) Patients with a prolonged QT interval. These patients 
may be at a higher risk of complex arrhythmias and 
sudden death. 
6) Patients with Marfan's syndrome and associated mitral 
valve prolapse because of the risk of aortic rupture and 
dissection. 
7) Patients with a family history of sudden death due to 
mitral valve prolapse. 
Risk of chordae tendineae rupture. Theoretically, pa•
tients with mitral valve prolapse and underlying mitral valve 
disease (regurgitant murmur, redundant leaflet and mitral 
anular dilation on echocardiography) may be at risk of de•
veloping ruptured chordae tendineae during strenuous ac•
tivities, particularly those associated with isometric strain 
and body contact. However, except for anecdotal experience 
(32), evidence for this increased risk is lacking and, thus, 
no recommendation can be made at this time to restrict 
athletic activities in patients with mitral valve prolapse to 
prevent ruptured chordae tendineae. 
Conclusion 
Idiopathic mitral valve prolapse has emerged during the 
past decade as the most common valvular disorder, affecting 
approximately 5% of the population. Although relatively 
less common in the young, it is probably more common 
than any other cardiac condition and it is being reported 
with increasing frequency in this age group. Its prognosis 
is generally benign; however, progression of mitral regur•
gitation, chordal rupture, infective endocarditis and sudden 
death do occur and, although rare, have shattered the illusion 
of that mitral valve prolapse is an innocent disorder. 
Although a restrictive approach to the performance of 
"exhaustive and highly competitive physical exercise" has 
been advocated by some investigators (2), a permissive at•
titude would seem warranted by the available evidence. 
However, this attitude should be modified by the presence 
of disabling chest pain, syncope, prolonged QT interval, 
complex ventricular arrhythmias, significant mitral regur•
gitation, Marfan's syndrome and a family history of sudden 
death. Most athletes presenting with these findings should 
probably be disqualified from strenuous and competitive 
activities. 
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